OORT DOUGLAS M VAN Insider Trading $NEO NEOGENOMICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for OORT DOUGLAS M VAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of OORT DOUGLAS M VAN. OORT DOUGLAS M VAN is Chairman and CEO in NEOGENOMICS INC ($NEO) and Director in BIOHITECH GLOBAL, INC. ($BHTG).
OORT DOUGLAS M VAN in NEOGENOMICS INC
Trading Symbol: NEOIndustry: SERVICES-TESTING LABORATORIES [8734]
Position of OORT DOUGLAS M VAN: Chairman and CEO
Holdings: 2,420,451 shares
Current Value: $19,460,426
Latest Transaction: Mar 03 2021
$NEO Market Capitalization: $625.74M
$NEO Previous Close: $8.04
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of OORT DOUGLAS M VAN in NEOGENOMICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2021 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 0.00 | 56,423 | 0 | 2,474,716 | 2.4 M to 2.5 M (+2.33 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 2,158 | 0 | 2,418,293 | 2.4 M to 2.4 M (-0.09 %) |
Mar 03 2021 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 2,339 | 0 | 2,420,451 | 2.4 M to 2.4 M (-0.10 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 20,000 | 150,400 | 0 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 20,000 | 150,400 | 0 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 358,752 | 2,697,815 | 20,000 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 358,752 | 2,697,815 | 20,000 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 121,248 | 911,785 | 378,752 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 121,248 | 911,785 | 378,752 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.34 | 100,000 | 4,234,000 | 2,422,790 | 2.5 M to 2.4 M (-3.96 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.34 | 100,000 | 4,234,000 | 2,422,790 | 2.5 M to 2.4 M (-3.96 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 20,000 | 150,400 | 2,522,790 | 2.5 M to 2.5 M (+0.80 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 20,000 | 150,400 | 2,522,790 | 2.5 M to 2.5 M (+0.80 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 41.56 | 118,752 | 4,935,333 | 2,502,790 | 2.6 M to 2.5 M (-4.53 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 41.56 | 118,752 | 4,935,333 | 2,502,790 | 2.6 M to 2.5 M (-4.53 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 358,752 | 2,697,815 | 2,621,542 | 2.3 M to 2.6 M (+15.85 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 358,752 | 2,697,815 | 2,621,542 | 2.3 M to 2.6 M (+15.85 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.18 | 121,248 | 5,114,241 | 2,262,790 | 2.4 M to 2.3 M (-5.09 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.18 | 121,248 | 5,114,241 | 2,262,790 | 2.4 M to 2.3 M (-5.09 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 121,248 | 911,785 | 2,384,038 | 2.3 M to 2.4 M (+5.36 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 121,248 | 911,785 | 2,384,038 | 2.3 M to 2.4 M (+5.36 %) |
Aug 13 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 10,000 | 0 | 2,262,790 | 2.3 M to 2.3 M (-0.44 %) |
Aug 13 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) |
Aug 13 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 5,000 | 0 | 2,272,790 | 2.3 M to 2.3 M (-0.22 %) |
Aug 13 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 10,000 | 0 | 2,277,790 | 2.3 M to 2.3 M (-0.44 %) |
Aug 04 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 5,953 | 0 | 2,287,790 | 2.3 M to 2.3 M (-0.26 %) |
May 27 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 22,330 | 0 | 2,293,743 | 2.3 M to 2.3 M (-0.96 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 28.33 | 225,084 | 6,376,630 | 225,084 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 0.00 | 34,945 | 0 | 2,316,073 | 2.3 M to 2.3 M (+1.53 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 2,353 | 0 | 2,281,128 | 2.3 M to 2.3 M (-0.10 %) |
Nov 21 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 24.08 | 187,500 | 4,515,000 | 0 | 187.5 K to 0 (-100.00 %) |
Nov 13 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.15 | 472,527 | 3,378,568 | 0 | |
Nov 13 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 205,635 | 0 | 2,277,391 | 2.5 M to 2.3 M (-8.28 %) |
Nov 13 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.15 | 472,527 | 3,378,568 | 2,483,026 | 2 M to 2.5 M (+23.50 %) |
Nov 13 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 6,090 | 0 | 2,010,499 | 2 M to 2 M (-0.30 %) |
Sep 03 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 10,000 | 0 | 2,016,589 | 2 M to 2 M (-0.49 %) |
Sep 03 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Sep 03 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 10,000 | 0 | 2,026,589 | 2 M to 2 M (-0.49 %) |
Sep 03 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 30,000 | 0 | 2,036,589 | 2.1 M to 2 M (-1.45 %) |
May 29 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 25,846 | 0 | 2,066,589 | 2.1 M to 2.1 M (-1.24 %) |
Mar 05 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 19.60 | 231,567 | 4,538,713 | 231,567 | |
Mar 05 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 0.00 | 37,883 | 0 | 2,092,435 | 2.1 M to 2.1 M (+1.84 %) |
Aug 03 2018 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 0.00 | 46,429 | 0 | 2,054,552 | 2 M to 2.1 M (+2.31 %) |
May 29 2018 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 0.00 | 65,680 | 0 | 131,362 | |
May 29 2018 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 11.57 | 21,904 | 253,429 | 1,876,761 | 1.9 M to 1.9 M (-1.15 %) |
May 29 2018 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 0.00 | 65,680 | 0 | 1,898,665 | 1.8 M to 1.9 M (+3.58 %) |
Feb 28 2018 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 8.03 | 636,000 | 5,107,080 | 636,000 | |
May 30 2017 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 0.00 | 197,042 | 0 | 197,042 | |
May 02 2017 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 7.52 | 500,000 | 3,760,000 | 500,000 | |
Feb 06 2017 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | X | 1.71 | 200,000 | 342,000 | 0 | |
Feb 06 2017 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 8.14 | 42,015 | 342,002 | 1,832,985 | 1.9 M to 1.8 M (-2.24 %) |
Feb 06 2017 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 1.71 | 200,000 | 342,000 | 1,875,000 | 1.7 M to 1.9 M (+11.94 %) |
May 27 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | X | 1.71 | 600,000 | 1,026,000 | 200,000 | |
May 27 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 8.74 | 383,000 | 3,347,420 | 1,675,000 | 2.1 M to 1.7 M (-18.61 %) |
May 27 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 8.69 | 98,387 | 854,983 | 2,058,000 | 2.2 M to 2.1 M (-4.56 %) |
May 27 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 8.65 | 118,613 | 1,026,002 | 2,156,387 | 2.3 M to 2.2 M (-5.21 %) |
May 27 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 1.71 | 600,000 | 1,026,000 | 2,275,000 | 1.7 M to 2.3 M (+35.82 %) |
May 03 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 7.15 | 472,527 | 3,378,568 | 472,527 | |
Mar 10 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | X | 0.80 | 1,000,000 | 800,000 | 0 | |
Mar 10 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 6.93 | 160,000 | 1,108,800 | 1,675,000 | 1.8 M to 1.7 M (-8.72 %) |
Mar 10 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 7.19 | 290,000 | 2,085,100 | 1,835,000 | 2.1 M to 1.8 M (-13.65 %) |
Mar 10 2016 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 0.80 | 1,000,000 | 800,000 | 2,125,000 | 1.1 M to 2.1 M (+88.89 %) |
Aug 18 2014 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 3.05 | 125,000 | 381,250 | 133,600 | 8.6 K to 133.6 K (+1,453.49 %) |
Mar 12 2014 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 1.05 | 375,000 | 393,750 | 250,000 | |
Mar 12 2014 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 1.05 | 187,500 | 196,875 | 187,500 | 0 to 187.5 K |
Mar 12 2014 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 1.05 | 187,500 | 196,875 | 991,456 | 804 K to 991.5 K (+23.32 %) |
Feb 16 2012 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 1.71 | 800,000 | 1,368,000 | 800,000 | |
Sep 16 2011 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | P | 1.14 | 2,500 | 2,850 | 803,956 | 801.5 K to 804 K (+0.31 %) |
Aug 23 2011 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | P | 1.15 | 2,000 | 2,300 | 801,456 | 799.5 K to 801.5 K (+0.25 %) |
Aug 08 2011 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | P | 1.30 | 2,000 | 2,600 | 799,456 | 797.5 K to 799.5 K (+0.25 %) |
Aug 08 2011 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | P | 1.25 | 500 | 625 | 795,500 | 795 K to 795.5 K (+0.06 %) |
Aug 08 2011 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | P | 1.30 | 1,956 | 2,543 | 797,456 | 795.5 K to 797.5 K (+0.25 %) |
Jun 14 2011 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | P | 1.35 | 2,500 | 3,375 | 795,000 | 792.5 K to 795 K (+0.32 %) |
May 26 2011 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | P | 1.40 | 2,500 | 3,500 | 792,500 | 790 K to 792.5 K (+0.32 %) |
May 20 2011 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | P | 1.40 | 1,110 | 1,554 | 790,000 | 788.9 K to 790 K (+0.14 %) |
May 20 2011 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | P | 1.40 | 1,000 | 1,400 | 788,890 | 787.9 K to 788.9 K (+0.13 %) |
May 12 2011 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | P | 1.40 | 600 | 840 | 787,890 | 787.3 K to 787.9 K (+0.08 %) |
May 09 2011 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | P | 1.45 | 5,000 | 7,250 | 787,290 | 782.3 K to 787.3 K (+0.64 %) |
Page: 1